AKT1 and liver cancer: Some evidence has also been reported suggesting that HULC can also act to inhibit c-Myc expression and PI3K/Akt signalling [129,130], and HULC has also been shown to cooperate with MALAT1 to promote liver cancer stem cell growth/aggressiveness [131].